Nexus Surgical & Medicare Ltd. (NEXUSSURGL.BO)
ValueMarkers Composite Index
82% below intrinsic value ($1)
Nexus Surgical & Medicare Ltd. (NEXUSSURGL.BO) — VMCI valuation read
Headline read on NEXUSSURGL.BO: VMCI of 56/100 versus a Healthcare sector median of 50. The 6-point above-median position is what makes Nexus Surgical & Medicare Ltd. a relative-value candidate in the mid-cap cohort, before any pillar-level review.
Form 4 filings on NEXUSSURGL.BO: zero in the trailing 30 days. The absence of insider transactions is itself a data point, just a low-information one. The thesis runs on financials and price action until that changes.
**Investor frame.** Three reads on NEXUSSURGL.BO: value (NEXUSSURGL.BO trades at 25.0x earnings, 39% above the Healthcare median of 18.0x), quality (ROIC of 11.0% sits 1.0pp above the Healthcare median (10.0%)), and risk (net debt to EBITDA of -0.4x leaves covenant headroom). The value read also implies an EV/EBITDA gap of +4.0x against the Healthcare 12.0x baseline.
NEXUSSURGL.BO fell 3.7% over the trailing 7 days, with a -16.3% read on a 30-day basis.
Related Stocks in Healthcare
Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.